Rani Therapeutics names president of CVS Kidney Care to its board

By Brian Buntz | January 7, 2022

Robotic drug-delivery pill company Rani Therapeutics Holdings (NSDQ:RANI) has added Lisa Rometty to its board of directors.

Rometty is the president of CVS Kidney Care. Previously, she worked as an executive at Syneos Health and IBM Watson Health.

Lisa Rometty

“I’m delighted to welcome Lisa to our Board,” said Talat Imran, CEO of Rani Therapeutics, in a statement. “Lisa’s expertise in commercializing new products and forming strategic partnerships will play a critical role in the ongoing development of the RaniPill technology and its anticipated future commercialization.”

“I’m thrilled to join this world-class team as we lay the groundwork for the future commercialization of their novel RaniPill technology and transform how people are treated with life-saving biologic therapies,” Rometty said in a LinkedIn update.

Filed Under: Gastroenterology, Immunology
Tagged With: Lisa Rometty, Rani Therapeutics, Rani Therapeutics Holdings

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at [email protected].